Acute Erythroleukemia

Search Trials
Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment
Status:
Unknown status
Last Changed:
Jul 10, 2013
First Changed:
Aug 23, 2011
Disease(s):
Leukemia
Intervention(s):
DNA methylation analysisRNA analysisgene expression analysismicroarray analysismutation analysisnucleic acid sequencinglaboratory biomarker analysis
Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia
Status:
Unknown status
Last Changed:
Jul 20, 2012
First Changed:
Feb 6, 2009
Disease(s):
Leukemia
Intervention(s):
clofarabinecytarabineidarubicin
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Dec 21, 2021
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
Status:
Unknown status
Last Changed:
Dec 19, 2013
First Changed:
Apr 10, 2003
Disease(s):
Leukemia
Intervention(s):
filgrastimamsacrinecyclophosphamidecytarabinedaunorubicin hydrochlorideetoposideidarubicinmitoxantrone hydrochloridethioguaninetretinoinallogeneic bone marrow transplantationautologous bone marrow transplantationperipheral blood stem cell transplantationradiation therapy
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Status:
Active, not recruiting
Last Changed:
Jun 8, 2022
First Changed:
Oct 26, 2006
Disease(s):
Acute Erythroid Leukemia
Intervention(s):
AzacitidineLaboratory Biomarker AnalysisPharmacological StudyVorinostat

Connect. Empower. Inspire.